期刊文献+

MTSS1基因表达异常及杂合性缺失在晚期胃癌发展及转移中的作用 被引量:7

Loss of heterozygosity and abnormal expression of MTSS1 in the progression and metastasis of advanced primary gastric carcinoma
原文传递
导出
摘要 目的:通过检测转移抑制因子1 (metastasis suppressor 1 ,MTSS1)基因在胃癌等组织中的表达,分析该基因在各组织中变化与胃癌预后的关系,并探讨该基因在胃癌发展及转移进程中变化的相关分子机制。方法:分别采用免疫组织化学法和RT-PCR法检测胃癌原发灶组织及其相应癌旁正常黏膜组织,淋巴结或其他转移灶组织中MTSS1的表达,并分析其与胃癌病理学参数的相关性。采用PCR-变性聚丙烯酰胺凝胶电泳银染法检测MTSS1阴性表达患者MTSS1基因位点上D8S1832、D8S2132、D8S1179和D8S14614等4个微卫星位点杂合性缺失(loss of heterozygosity, LOH)的情况。结果:MTSS1在胃癌原发灶组织中阳性表达率为33.9% (42/124),在胃癌淋巴结及其他转移灶中阳性表达率仅为16.3% (8/49)。MTSS1表达缺失与胃癌肿瘤的分化程度、浸润程度较深、发生淋巴结转移以及疾病分期晚等均明显相关。单因素与多因素分析均提示,MTSS1表达下降或缺失的胃癌患者预后较差。在MTSS1表达阴性的胃癌原发及转移组织中LOH发生率较高,总LOH率分别为46.2%和 69.2%。结论:MTSS1表达下降或缺失在胃癌的发生、发展过程中可能起着重要作用,基因可能与胃癌患者的预后密切相关。 Objective:To determine the correlation of metastasis suppressor 1(MTSS1) gene with the prognosis of gastric cancer by detecting the expression level of MTSS1 in gastric cancer,and to explore its underlying molecular mechanism in the development and progression of gastric cancers.Methods:The expression levels of MTSS1 in the primary lesion,adjacent normal mucosa tissue,lymph node metastasis and other metastatic lesions from patients with gastric cancer were detected by using immunohistochemistry and RT-PCR,and the correlation of MTSS1 expression with the clinicopathological factors was evaluated.The loss of heterozygosity(LOH) of four microsatellite loci(D8S1832,D8S2132,D8S1179 and D8S1461) in MTSS1 gene in thirteen patients with negative-expression of MTSS1 was detected by using PCR-polyacrylamide gel electrophoresis-silver staining method.Results:The positive expression rates of MTSS1 were 33.9%(42/124) in the primary lesions and 16.3%(8/49) in the lymph node metastasis and other metastatic lesions.Loss expression of MTSS1 was significantly associated with the advanced T stage,lymph node metastasis,advanced disease stage,and the poor histological differentiation.Loss or down-regulation of MTSS1 expression was significantly correlated with the poor survival rate in both univariate and multivariate analysis.A higher frequency of allelic loss was observed in the primary(46.2%) or metastatic(69.2%) gastic cancer lesion with negative expression of MTSS1.Conclusion:The loss and decreased expression of MTSS1 may play an important role in the development and progression of gastric cancers,and MTSS1 gene may become a potential predictor for clinical outcome of patients with gastric cancer.
出处 《肿瘤》 CAS CSCD 北大核心 2011年第3期255-260,共6页 Tumor
关键词 胃肿瘤 肿瘤抑制蛋白质类 免疫组织化学 预后 Stomach neoplasms Tumor suppressor proteins Immunohistochemistry Prognosis
  • 相关文献

参考文献2

二级参考文献4

  • 1Dai D Q,Chin J Cancer Res,1995年,7卷,148页
  • 2Shiozaki H,Am J Pathol,1994年,144卷,667页
  • 3Mayer B,Cancer Res,1993年,53卷,1690页
  • 4Chen J Q,Chin J Cancer Res,1991年,3卷,45页

共引文献44

同被引文献50

  • 1高春芳,李冬晖,赵光,郑国宝,王秀丽,许红兵.胃癌患者血清比较蛋白质组学研究[J].解放军医学杂志,2005,30(6):457-459. 被引量:20
  • 2梁勇,刘池波,李继承.血清蛋白质谱模型对胃腺癌诊断的应用性研究[J].中国肿瘤,2006,15(2):127-130. 被引量:6
  • 3潘春琴,刘池波,梁勇,孙灵芬,管涛.SELDI-TOF-MS技术对胃炎诊断的应用[J].浙江医学,2006,28(12):970-972. 被引量:12
  • 4Koike H,Ichikawa D,Ikoma H,et al.Comparison of serum aberrant methylation and conventional tumor markers in gastric carcinoma patients[J].Hepatogastroenterology,2005,52(64):1293-1296.
  • 5Mattar R,de Andrade A,DiFavero GM,et al.Preoperative serum levels of CA72-4,CEA,CA19-9,and alpha-fetoprotein in patients with gastric cancer[J].Rev Hosp Clin Fac Med Sao Paulo,2002,57(3):89-92.
  • 6Weinberger SR,Boschetti E,Santambien P,et al.Su-rface enhanced laser desorption/ionization retentate chromatography mass spectrometry (SELDI-RC-MS);A new method for rapid development of process chromatography conditions[J].J Chromatogr B Analyt Technol Biomed Life Sci,2002,782(1/2):307-316.
  • 7Bane TK,Leblanc JF,Lee TD,et al.DNA affinity ca-pture and protein profiling by SELDI-TOF mass spectromeltry effect of DNA methylation[J].Nucleic Acids Res,2002,30(14):58-69.
  • 8Service RF.Genetics and medicine:Recruiting genes,proteins for a revolution in diagnostics[J].Science,2003,300(5617):236-239.
  • 9Seibert V,Ebert MP,Buschmann T.Advances in cli-nical carcinoma proteomics:SELDI-TOF mass spectrometry and biomarker discovery[J].Brief Funct Genomic Proteomic,2005,4(1):16-26.
  • 10南京中医药大学.中药大辞典[M].上海:上海科学技术出版社,2012:23-24.

引证文献7

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部